BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

773 related articles for article (PubMed ID: 20618508)

  • 1. Cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Ding WY; Lee CK; Choon SE
    Int J Dermatol; 2010 Jul; 49(7):834-41. PubMed ID: 20618508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An epidemiological and clinical analysis of cutaneous adverse drug reactions seen in a tertiary hospital in Johor, Malaysia.
    Choon SE; Lai NM
    Indian J Dermatol Venereol Leprol; 2012; 78(6):734-9. PubMed ID: 23075643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous adverse drug reactions: clinical pattern and causative agents--a 6 year series from Chandigarh, India.
    Sharma VK; Sethuraman G; Kumar B
    J Postgrad Med; 2001; 47(2):95-9. PubMed ID: 11832597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional study of cutaneous drug reactions in a private dental college and government medical college in eastern India.
    Chattopadhyay C; Chakrabarti N
    Niger J Clin Pract; 2012; 15(2):194-8. PubMed ID: 22718172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital.
    Sushma M; Noel MV; Ritika MC; James J; Guido S
    Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):567-70. PubMed ID: 15937869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological study of severe cutaneous adverse drug reactions in a city district of China.
    Li LF; Ma C
    Clin Exp Dermatol; 2006 Sep; 31(5):642-7. PubMed ID: 16901302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
    Kim HK; Kim DY; Bae EK; Kim DW
    J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of cutaneous adverse drug reactions.
    Mockenhaupt M
    Chem Immunol Allergy; 2012; 97():1-17. PubMed ID: 22613850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 10-years retrospective study on Severe Cutaneous Adverse Reactions (SCARs) in a tertiary hospital in Penang, Malaysia.
    Loo CH; Tan WC; Khor YH; Chan LC
    Med J Malaysia; 2018 Apr; 73(2):73-77. PubMed ID: 29703869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective analysis of adverse cutaneous drug reactions in patients hospitalized in Department of Dermatology and Venereology of Pomeranian Medical University in 1996-2006].
    Kacalak-Rzepka A; Klimowicz A; Bielecka-Grzela S; Załuga E; Maleszka R; Fabiańczyk H
    Ann Acad Med Stetin; 2008; 54(2):52-8. PubMed ID: 19374232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of cutaneous adverse drug reactions among medical inpatients of Sultanah Aminah Hospital Johor Bahru.
    Latha S; Choon SE
    Med J Malaysia; 2017 Jun; 72(3):151-156. PubMed ID: 28733562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe adverse cutaneous drug eruptions: epidemiological and clinical features.
    Zaraa I; Jones M; Trojjet S; Cheikh Rouhou R; El Euch D; Mokni M; Ben Osman A
    Int J Dermatol; 2011 Jul; 50(7):877-80. PubMed ID: 21699528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous adverse drug reactions in children. A series of 90 cases.
    Khaled A; Kharfi M; Ben Hamida M; El Fekih N; El Aidli S; Zeglaoui F; Ezzine N; Fazaa B; Kamoun MR
    Tunis Med; 2012 Jan; 90(1):45-50. PubMed ID: 22311448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous reactions to non-steroidal anti-inflammatory drugs.
    Kasemsarn P; Kulthanan K; Tuchinda P; Dhana N; Jongjarearnprasert K
    J Drugs Dermatol; 2011 Oct; 10(10):1160-7. PubMed ID: 21968666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.